M oyaMoya disease (MMD) is characterized by progressive occlusion at the terminal portions of the bilateral internal carotid arteries and their main branches within the circle of Willis and the basal collateral arterial network (moyamoya vessels). 5, 14, 20, 33 Although MMD is an uncommon cerebrovascular disorder, it is an important cause of stroke in children and young adults. 5, 14, 20, 33 MMD is a heterogeneous entity. The disease occurs in children and adults, but the clinical features are differ-ABBREVIATIONS CB = combined bypass; DB = direct bypass; DSA = digital subtraction angiography; EDAS = encephaloduroarteriosynangiosis; IB = indirect bypass; ICH = intracerebral hemorrhage; IVH = intraventricular hemorrhage; MCA = middle cerebral artery; MMD = moyamoya disease; mRS = modified Rankin Scale; SAH = subarachnoid hemorrhage; STA = superficial temporal artery; TIA = transient ischemic attack. OBJECTIVE Bypass surgery is the most common treatment for moyamoya disease (MMD), but there is controversy over which surgical modality is best. The objective of this study was to evaluate the clinical outcome of patients with MMD after undergoing different surgical modalities. METHODS A series of 696 consecutive MMD patients treated between June 2009 and May 2015 were screened in this prospective cohort study. Patients who did not undergo revascularization surgeries and those who underwent different surgical modalities in bilateral hemispheres were excluded. Finally, 529 patients who were observed for at least 12 months were included: 438 patients underwent unilateral surgery, and 91 patients underwent bilateral surgery. Of these, 241 patients underwent direct bypass (DB); 81, a combined bypass (CB); and 207, an indirect bypass (IB). Three clinical outcomes were evaluated and compared between surgical groups: recurrent stroke events, modified Rankin Scale (mRS) scores, and change in the main symptoms. RESULTS The mean follow-up period was 40 months. During the follow-up period, recurrent stroke was observed in 43 patients, including 15 patients with hemorrhage, 26 patients with ischemia (transient ischemic attack in 19 patients and infarction in 7 patients), and 2 patients with both hemorrhage and cerebral infarction. Kaplan-Meier analysis showed that patients who underwent a CB or DB had a longer ischemia-free time than those who underwent IB (p = 0.013); however, there was no significant difference in the hemorrhage-free time between the different surgical modalities (p = 0.534). A good neurological status (mRS score ≤ 2) was achieved in 495 patients (93.6%) and was significantly achieved by more children (98.2%) than adults (92.3%; p = 0.022). Surgical modalities were not significantly associated with outcome neurological status (p = 0.860). Moreover, improvement in symptoms was observed in 449 patients (84.9%) and was also significantly more common in children (93.0%) than in adults (82.7%; p = 0.006). No significant difference was observed between the different surgical modalities (p = 0.548). CONCLUSIONS CB and DB are more effective at preventing recurrent ischemic strokes than IB. However, there is no evidence that these 3 surgical modalities demonstrate significant differences in preventing recurrent hemorrhage.
ent. 2, 7, [18] [19] [20] 27, 30, 33 Moreover, the disease manifests in several ways, including cerebral infarction, intracranial hemorrhage, transient ischemic attack (TIA), and other types of stroke. 4, 9, 10, 11, 14 The ideal treatment should be effective in improving symptoms and preventing recurrent stroke. Currently, most authors are in favor of surgical revascularization. However, because of the heterogeneity of this disease, the optimal surgical modality for MMD remains unclear, and the effects of different surgical procedures remain a matter of debate. 1, 3, 6, 12, 13, 15, 21, 22, 28, 32 Therefore, we performed this prospective cohort study to evaluate the effects of different surgical modalities on the clinical outcome of MMD in a large series of patients who underwent various types of surgical procedures.
Methods

Study Design and Participants
This is a single-center registry, prospective cohort study on the surgical treatment for MMD. The study protocol was approved by the institutional review board of Beijing Tiantan Hospital, Capital Medical University, and the procedures were followed in accordance with institutional guidelines. All MMD patients (including those with unilateral MMD) who were diagnosed using digital subtraction angiography (DSA) and/or MR angiography at Stroke Center Ward 3 of our institution between June 2009 and May 2015 were screened. Written informed consent was obtained from all patients. Diagnosis was based on the guidelines for MMD (the 2012 criteria of the Research Committee on Spontaneous Occlusion of the Circle of Willis). 10 Patients with moyamoya syndrome secondary to the identified etiologies were excluded.
Baseline Data Collection
Clinical and imaging data were collected. According to the guidelines for MMD, the disease type that manifested as the initial attack was categorized into 7 types: cerebral infarction, intracranial hemorrhage, TIA, frequent TIAs (≥ 2 times per month), headache, epilepsy, and asymptomatic disease. 10 Patients without cerebral infarction (infarction group) or intracranial hemorrhage (hemorrhage group) were combined into the "other" group. Neurological status was evaluated using the modified Rankin Scale (mRS) score on admission and at follow-up. 23 
Surgical Modalities
Three different bypass procedures were performed to treat MMD: combined bypass (CB), direct bypass (DB), and indirect bypass (IB). In DB, end-to-side anastomosis of the branches of the superficial temporal artery (STA) to the cortical branches of the middle cerebral artery (MCA) was performed. Briefly, the course of the STA was mapped, and the posterior branch of the STA was usually selected. The STA was dissected free, the surrounding connective tissues were removed, and a small craniotomy (diameter 3-5 cm) was performed over the sylvian fissure. The dura was opened, the M 4 branch of the MCA was selected as the recipient artery, and end-to-side anastomosis was performed. After anastomosis, graft patency was usually confirmed using intraoperative indocyanine green videoangiography. IB involved encephaloduroarteriosynangiosis (EDAS) and drilling multiple bur holes. For EDAS, the STA and accompanying cuff of the galea connective tissue were exposed and then overlaid and sutured onto the brain surface. For multiple bur holes, 5-15 bur holes were placed over the hypoperfusion brain area, and the underlying dura was incised and separated. If both DB and IB procedures were performed in 1 hemisphere, it was considered as CB.
The principles of the surgical strategies were as follows. First, patient selection for surgical treatment was mainly based on clinical presentation. The symptomatic hemisphere was the preferred side for revascularization surgery. For patients without an obvious symptomatic hemisphere, the results of the CT perfusion studies were evaluated, and the hemisphere with lower perfusion was treated first. Second, if the patient's symptoms significantly improved after the first surgery and the patient did not present with symptoms in the contralateral hemisphere, an operation in the contralateral hemisphere was not considered. Third, CB and DB were the favored surgical modalities for most patients, whether in children or adult patients or in ischemic or hemorrhagic patients. An IB was performed only when the donor or recipient artery was too small or fragile to perform artery anastomosis. Moreover, for patients in the acute phase (within 3 months) of intracranial hemorrhage or cerebral infarction, bypass surgery was not considered.
Follow-Up
Patients underwent follow-up at the clinic or by telephone interview 3-6 months after surgery and annually thereafter. The doctors who performed the follow-up assessments were blinded to the surgical groups. The following 3 clinical outcomes were evaluated: recurrent stroke as the primary follow-up event, including intracranial hemorrhagic and cerebral ischemic events; neurological status (mRS score), which was classified as good (mRS score ≤ 2) or poor (mRS score ≥ 3); and change in symptoms, which was classified as improved or not improved (including stable, deteriorated, and dead).
Statistical Analysis
All statistical analyses were performed using SPSS (Windows version 22.0; IBM). Continuous data that met and did not meet the normal distribution were compared using the t-test and rank-sum test, respectively. Categorical data were compared using the chi-square test. Ordinal variables (mRS score and Suzuki stage) were analyzed using the rank-sum test. Logistic regression analysis was used for multivariable analysis. The stroke-free time from the recurrent ischemic and hemorrhagic events was estimated using Kaplan-Meier curves with log-rank statistics. Multivariate Cox regression with a forward stepwise regression procedure was used to determine the significance of several variables for predicting the hazard ratio of recurrent stroke. Odds ratios with 95% confidence intervals are presented. A probability value < 0.05 was considered statistically significant.
Results
We identified 696 consecutive MMD patients, of whom 657 patients underwent revascularization procedures. Sixty-seven patients who underwent different surgical modalities in each hemisphere were excluded (Fig. 1) . Therefore, 590 patients were enrolled in this study, including 486 patients who underwent unilateral operations and 104 patients who underwent bilateral operations. These 590 patients underwent follow-up, but 61 patients (10.3%) were lost to follow-up or were observed for less than 12 months. Finally, 529 patients (89.7%) who were observed in followup for at least 12 months were included (Fig. 1 ).
There were no significant differences in the baseline risk factors or surgical modalities between the 529 included patients and the 61 patients lost to follow-up (p > 0.05) ( Table 1) .
Data on All 696 Patients
Demographic Data
There were 316 male and 380 female patients (male/ female ratio 1:1.20). The age at diagnosis ranged from 2 to 63 years, and the median age was 34.5 years. The age at diagnosis had an obvious bimodal distribution: 1 moderate peak was observed at 5-13 years and a higher peak at 35-49 years (Fig. 2 ). There were 155 children (< 17 years old) and 541 adults (≥ 17 years old), with a child/adult ratio of 1:3.49.
Regarding patient ethnicity, the majority were Han Chinese (686 patients; 98.6%), 4 were Manchu, 2 were Zhuang, 2 were Hui, 1 was Mongolian, and 1 was Dong. The geographical distribution analysis showed that the provinces with the largest number of patients were Hebei (n = 120), Henan (n = 114), and Shandong (n = 110). The remaining 352 patients were from 24 different provinces (Fig. 3) .
Disease Type Manifesting at the Initial Attack
As shown in Table 2 , the most common disease type that manifested at the initial attack was cerebral infarction (233 patients; 33.5%) followed by TIA (181 patients; 26.0%), intracranial hemorrhage (176 patients; 25.3%), headache (43 patients; 6.2%), frequent TIAs (38 patients; 5.5%), epilepsy (20 patients; 2.8%), and asymptomatic disease (5 patients; 0.7%).
Different disease types manifested between children and adults (Table 2 ). In children, the most common disease was TIA (40.6%), followed by cerebral infarction (29.0%) and headache (11.0%), whereas the most common disease in adult patients was cerebral infarction (34.8%), followed by intracranial hemorrhage (31.1%) and TIA (21.8%). The percentage of patients with hemorrhage was significantly greater in adults (31.1%) than in children (5.1%) (p < 0.001; OR 8.276, 95% CI 3.970-17.251). The percentages of patients with TIA, headache, and epilepsy were significantly higher in children than in adults (p < 0.05).
The types of intracranial hemorrhage included intraventricular hemorrhage (IVH) (81 patients; 46.0%) followed by intracerebral hemorrhage (ICH) (45 patients; 25.6%), IVH with ICH (17 patients; 9.7%), subarachnoid hemorrhage (SAH) (14 patients; 7.9%), ICH with SAH (3 patients; 1.7%), and IVH with SAH (2 patients; 1.1%). The hemorrhage types of the other 14 patients (7.9%) were unclear because their CT scans were performed at a different institution.
Data on the 529 Included Patients
Demographic Data
There were 248 male and 281 female patients, of whom 114 were children and 415 were adults. The median age was 34 years (range 2-63 years). The disease type included cerebral infarction in 184 patients, intracranial hemorrhage in 142 patients, and "other" in 203 patients (Table  3 ). The median ages of these disease groups were 37, 39, and 27 years, respectively. Therefore, the patients in the "other" group were significantly younger than those in the infarction and hemorrhage groups (p < 0.001).
Angiography Findings
According to DSA and MR angiography examination findings, 69 patients were diagnosed with unilateral MMD (13.0%) and 460 patients (87.0%) with bilateral involvement. Preoperative DSA images were obtained and analyzed in 453 patients (85.6%), and their Suzuki stages are shown in Table 3 . 20 The median stage was IV.
Neurological Status on Admission
On admission, there was no significant difference in the mRS scores between children and adults (p = 0.082) ( Table 4) or between the surgical modalities (p = 0.379). The patients in the "other" group had significantly lower mRS scores compared with the infarction group and hemorrhage group (p = 0.011).
Surgical Modalities
A total of 620 surgical procedures were performed in the included 529 patients, including 438 patients who un- derwent unilateral surgery and 91 patients who underwent bilateral surgery. The surgical procedures are detailed in Table 5 . In total, CB was performed in 81 patients, DB was performed in 241 patients, and IB was performed in 207 patients. Among the different surgical modalities, significant differences were observed in terms of age, sex distribution, bilateral operations, unilateral MMD involvement, and Suzuki stage (Table 3) . Compared with patients who underwent DB or CB, those who underwent IB were significantly younger (p < 0.001), and there were greater proportions of children (p < 0.001), female patients (p = 0.040), bilateral hemisphere operations (p < 0.001), and unilateral disease involvement (p = 0.014). Patients who underwent DB had a lower Suzuki stage than those who underwent CB or IB (p = 0.026). There were no significant differences in the disease types among the different surgical modalities (p = 0.198). 
Surgical Complications
Of the 620 surgical procedures, complications were observed in 58 operations (9.4%), including a new infarction in 23 (3.7%) patients, hyperperfusion in 13 (2.1%) patients, epilepsy in 8 (1.3%) patients, wound infection in 5 (0.8%) patients, subdural effusion in 5 (0.8%) patients, intracranial hemorrhage in 4 (0.6%) patients, and bacterial meningitis in 1 (0.1%) patient. For the 262 DB procedures, complications were detected in 30 (11.5%) patients, including a new infarction in 10 (3.8%) patients, hyperperfusion in 9 (3.4%) patients, wound infection in 4 (1.5%) patients, epilepsy in 3 (1.1%) patients, subdural effusion in 2 (0.8%) patients, and intracranial hemorrhage in 2 (0.8%) patients. For the 269 IB procedures, complications were detected in 21 (7.8%) patients, including a new infarction in 11 (4.1%) patients, epilepsy in 4 (1.5%) patients, hyperperfusion in 2 (0.7%) patients, subdural effusion in 2 (0.7%) patients, and intracranial hemorrhage in 2 (0.7%) patients. For the 89 CB procedures, complications were detected in 7 (7.9%) patients, including a new infarction in 2 (2.2%) patients, hyperperfusion in 2 (2.2%) patients, wound infection in 1 (1.1%) patient, epilepsy in 1 (1.1%) patient, and wound infection in 1 (1.1%) patient. Therefore, although the incidence of complications was higher in patients who underwent DB (11.5%) than in those who underwent IB (7.8%) and CB (7.9%), there was no significant difference (p = 0.309). There were no instances of perioperative mortality.
Follow-Up Period
The follow-up period ranged from 12 to 82 months, with a mean of 40 months.
Recurrent Stroke Events
Recurrent stroke events were observed in 43 patients, including 15 patients with hemorrhage, 26 patients with ischemia (TIA in 19 patients and infarction in 7 patients), and 2 patients with both hemorrhage and cerebral infarction. These events occurred 1-57 months after surgery (median 17 months).
Results of the Kaplan-Meier analysis are shown in Table 6 . Among all 529 patients, the ischemia-free time was significantly longer in patients who underwent CB (76 months) or DB (73 months) than in those who underwent IB (65 months) (p = 0.013) (Fig. 4A) . This was also demonstrated by multivariate Cox regression analysis (p = 0.008; HR 1.861, 95% CI 1.178-2.942), and the other factors (e.g., sex, age, disease type) were not significant. No significant difference was observed in the hemorrhage-free times among the different surgical modalities (p = 0.534) (Fig.  4B) . There was no significant difference in either the ischemia-free time or hemorrhage-free time between children and adults (p = 0.134 and 0.131, respectively). The patients in the "other" group had the longest stroke-free time, both in terms of recurrent ischemia (p = 0.053) and hemorrhage (p = 0.003).
Moreover, for the 184 patients with cerebral infarction, Kaplan-Meier analysis demonstrated that patients who underwent DB had the longest ischemia-free time (73.689 ± 0.916 months), followed by patients who underwent CB (62.793 ± 3.374 months) and IB (62.793 ± 3.374 months) (p = 0.009) (Fig. 4C) . This was also demonstrated by the Cox regression analysis (p = 0.005; HR 2.696, 95% CI 1.343-5.414), and the other factors were not significant. There was no significant difference among the different surgical modalities, neither in terms of the hemorrhage-free time for the patients in the hemorrhage group (p = 0.847) (Fig.  4D ) nor in terms of the ischemia-free time for the patients in the "other" group (p = 0.274).
Neurological Status
As shown in Table 7 , at the last follow-up, good neurological status (mRS score ≤ 2) was observed in 495 patients (93.6%); significantly more children (112 of 114 patients; 98.2%) had a good outcome than adults (383 of 415 patients; 92.3%) (p = 0.022). There were no significant differences among the different surgical modalities in terms of the incidence of good neurological status (in all 529 patients Logistic regression analysis also demonstrated that age was the only significant factor affecting neurological status (p = 0.036), and the other factors-including sex, disease type, associated diseases, unilateral involvement, unilateral or bilateral operations, and surgical modalities-were not significantly associated with the long-term neurological outcome (p > 0.05). Values are shown in months (mean ± SD) unless otherwise indicated.
Changes in Symptoms
Compared with the preoperative symptoms, at last follow-up the symptoms had improved in 449 patients (84.9%), were stable in 29 patients (5.5%), or had deteriorated in 40 patients (7.6%), and 11 patients (2.1%) were dead. The causes of death were intracranial rebleeding in 6 patients, cerebral infarction in 1 patient, myocardial infarction in 1 patient, and unclear in the other 3 patients.
The effects of the different surgical modalities on the changes in symptoms were analyzed (Table 7 ). There were no significant differences among the different surgical modalities in all 529 patients (p = 0.548), in the infarction group (p = 0.367), hemorrhage group (p = 0.870), or the "other" group (p = 0.506). Moreover, age was also considered as a factor. For children, the surgical modalities were not significantly associated with the improvement rate in all 114 children (p = 0.579) or the different disease type groups (p > 0.05). Likewise, for adults, no significant differences were noted in the improvement rate among the different surgical modalities in all 415 adult patients (p = 0.942) or in the different disease type groups (p > 0.05).
The chi-square test showed that the improvement in symptoms was significantly greater in children (106 of 114 patients; 93.0%) than in adults (343 of 415 patients; 82.7%) (p = 0.006) and significantly higher in the "other" group (90.6%) than in the infarction group (82.1%; p = 0.014) and hemorrhage group (80.3%; p = 0.006). Other factors were not significant. However, logistic regression analysis showed that age was the only significant factor that affected changes in clinical symptoms (p = 0.009), and the other factors were not significant (p > 0.05).
Discussion
Epidemiology of MMD in China
MMD was first reported and is most well known to occur in Japan. 4, 11, 20, 22, 30, 33 Meanwhile, in recent years an increase of patients with MMD has been seen in China. Compared with Japanese populations, Chinese patients with MMD may have different epidemiological features. First, a female predominance has been reported in Japan, with a sex ratio (male/female) of 1:1.8. 8, 19 This female predominance was even more obvious in European and American populations (1:2.5 and 1:4.25, respectively). 5, 18 However, 2 studies with large cohorts from China showed no sex predominance, and the male/female ratios were 1:1.0 and 1:0.9, respectively. 7, 24 In our study, the male/female ratio was 1:1.2, which also suggested that there was no obvious difference in the sex distribution. Second, although there is a bimodal peak in the age distribution in Japanese populations (major peak in the 1st decade of life and moderate peak in late 20s to 30s), the disease was more often found in children than adults. 10, 28 However, studies on Chinese populations have shown a preponderance of adults. 7, 24 The present study also revealed a bimodal age distribution, but the higher peak was at 35-49 years and the moderate peak at 5-13 years. Meanwhile, the majority of patients with MMD were adults, with a child/adult ratio of 1:3.49. Third, the clinical presentation at the initial attack differed. In Japan, in the 962 registered MMD patients, the most common disease was TIA (37%), followed by hemorrhage (19%), infarction (17%), and other diseases. 10 In the current study, the most common presentation was cerebral infarction (33.5%), followed by TIA (26.0%), intracranial hemorrhage (25.3%), and other diseases. Therefore, the diseases that manifest at the initial attack differ between Chinese and Japanese populations.
Effects of Surgical Modalities on Clinical Outcome
The optimal surgical procedure for MMD remains controversial. The heterogeneity of this disease (with respect to, for example, age, disease type, Suzuki stage) might lead to differences in surgical outcomes in different studies. Theoretically, DB can directly improve cerebral hemodynamics and resolve ischemic and hemorrhagic attacks immediately after surgery. 3 IB can lead to surgical collaterals, which may develop 3-4 months after surgery. 20 However, there are some drawbacks to both DB and IB. DB requires both good donor and recipient arteries, which do not exist in some patients. Moreover, DB could improve cerebral blood flow immediately after surgery, which might bring about symptomatic hyperperfusion or even hemorrhage. 6, 15, 16, 28 CB and DB are more challenging procedures for neurosurgeons and require longer operative durations. In contrast, IB is generally considered easier, safer, and more feasible in patients with inadequate recipient or donor arteries. However, it has also been reported that collateral pathways do not develop in about 40%-50% of adult patients. 13, 20 Currently, some authors favor DB or CB over IB. 15, 17, 26, 29, 31, 32, 34 However, the results from other studies do not support the advantages of CB or DB. 6, 9 To study ischemic MMD, Lee et al. enrolled 142 MMD patients (including 89 ischemic and 35 hemorrhagic patients who underwent surgical treatment), and their results showed that CB and DB were more effective than IB at preventing recurrent ischemic stroke. 21 However, Duan et al. enrolled 802 MMD patients, including 564 ischemic MMD patients. The majority of patients (90.6%) underwent IB, and a good clinical outcome was also achieved. 7 In hemorrhagic patients, Liu et al. enrolled 97 patients with hemorrhagic MMD, and their findings showed that DB was more effective in preventing rebleeding than IB. 24 However, in both Lee et al.'s and Huang et al.'s studies, there was no significant difference in rebleeding between the patients who underwent CB, DB, or IB. 12, 21 Moreover, in the most recent meta-analysis, Macyszyn et al. included 33 studies involving 4197 surgically treated hemispheres. 25 They concluded that IB and CB were superior to DB.
Our study showed that different surgical modalities had no significant difference on long-term clinical outcome. The only independent risk factor was age, and children had a significantly better prognosis than adults, both in terms of changes in symptoms and long-term neurological status. However, CB and DB were superior in preventing recurrent ischemic stroke events compared with IB, especially in infarction patients. Therefore, the results in terms of clinical outcome and the results in terms of recurrent stroke events seem to be conflicting. We think the difference in results might be attributed to the large proportion of recurrent is- Compared with previous studies, our study has some advantages. First, we enrolled a large number of patients. To the best of our knowledge, this is the largest series of MMD patients, with most patients undergoing DB or CB procedures. Second, to resolve the effects of heterogeneity on clinical outcome, the statistical analysis was separately performed in different groups and subgroups, including different age groups and disease types. Third, MMD patients were divided into hemorrhagic and ischemic groups in most previous studies. Patients without hemorrhage were considered ischemic. However, our study showed that among ischemic patients there were significant differences in the clinical features between the infarction group and the "other" group. For example, the patients in the "other" group (median age 27 years) were significantly younger than those in the infarction group (median age 37 years). Moreover, the "other" group had the lowest mRS scores on admission and had the longest stroke-free time after surgery. Therefore, we believe patients with other disease types (e.g., TIA, frequent TIAs, epilepsy) are an entity and should be distinguished from patients with cerebral infarction. Finally, we used 3 methods to evaluate clinical outcome, including recurrent stoke events, mRS score, and change in symptoms. These indicators are complementary and can fully reflect the patient's clinical outcome.
Limitations of the Study
The present study has several limitations. First, it is not a randomized controlled trial. For ethical reasons, a randomized trial could not be performed. There is potential bias in the patient selection for different surgical procedures, which might affect the results. Second, this is a single-center study, and referral and selection bias cannot be excluded. Moreover, the follow-up period might not be long enough to draw positive conclusions. A multicenter clinical trial with a longer follow-up is needed to further confirm our conclusions, which is the next step of our research.
Conclusions
This prospective cohort study has demonstrated that CB, DB, and IB have similar effects on long-term clinical outcome, but CB and DB are superior in preventing recurrent ischemic stroke events. For hemorrhagic patients, there is no evidence that CB and DB are more effective in preventing rebleeding. Children have a better prognosis than adults.
